<DOC>
	<DOC>NCT01166555</DOC>
	<brief_summary>This study will evaluate the safety, tolerability, and pharmacokinetics of PF-04236921 administered as a single subcutaneous dose in healthy volunteers.</brief_summary>
	<brief_title>Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy Volunteers</brief_title>
	<detailed_description>Tolerability and Pharmacokinetics of subcutaneously administered dose of PF-04236921 in healthy volunteers</detailed_description>
	<criteria>Healthy males between 1855 years, inclusive. Healthy females of nonchildbearing potential between 18 and 55 years, inclusive. Evidence or history of clinically significant disease. Females of childbearing potential.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Safety and tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>PF-04236921</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
</DOC>